Literature DB >> 17496573

Transmission of human herpesvirus 8: an update.

Francesca Pica1, Antonio Volpi.   

Abstract

PURPOSE OF REVIEW: Human herpesvirus 8 is associated with neoplastic diseases in the immunocompromised host, including Kaposi's sarcoma, multicentric Castleman disease and primary effusion lymphoma. Acquisition and control of human herpesvirus 8 infection have not yet been fully elucidated. This review focuses on the most recent findings on human herpesvirus 8 transmission. RECENT
FINDINGS: Horizontal transmission by saliva appears the most common route not only in families in endemic regions, but also among high-risk groups in Western countries. Vertical, sexual, and blood and transplant-related transmission, however, remain of significant concern worldwide. Novel approaches to standardize and optimize the assessment of human herpesvirus 8 infection have been reported. New insights on the host immune cell mechanisms devoted to the control of human herpesvirus 8 infection have also been presented.
SUMMARY: The increasing knowledge about the routes of human herpesvirus 8 transmission, which appear now more similar to those of other more ubiquitous human herpesviruses (i.e. Epstein-Barr virus and cytomegalovirus), the growing efforts in improving laboratory diagnosis and the caution in the research of new biological associations are the major recent findings. They constitute a fundamental background for directing more appropriate future research and achieving more stringent evidence useful for the control of human herpesvirus 8 spread and for the management of human herpesvirus 8-related diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17496573     DOI: 10.1097/QCO.0b013e3280143919

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  28 in total

Review 1.  Vaccines to prevent infections by oncoviruses.

Authors:  John T Schiller; Douglas R Lowy
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

2.  Rapid regression of Kaposi's sarcoma of the hard palate under therapy with boosted elvitegravir-containing fixdose antiretroviral combination therapy.

Authors:  Gundolf Schüttfort; Timo Wolf; Phillip de Leuw; Gerrit Kann; Maximilian Blume; Hans-Reinhard Brodt; Christoph Stephan
Journal:  Infection       Date:  2015-05-07       Impact factor: 3.553

3.  LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells.

Authors:  David C Brice; Zsolt Toth; Gill Diamond
Journal:  Antiviral Res       Date:  2018-08-02       Impact factor: 5.970

4.  Update on HHV-8-Associated Malignancies.

Authors:  Meena Sunil; Erin Reid; Mary Jo Lechowicz
Journal:  Curr Infect Dis Rep       Date:  2010-03-26       Impact factor: 3.725

5.  Prevalence of viremia and oral shedding of rhesus rhadinovirus and retroperitoneal fibromatosis herpesvirus in large age-structured breeding groups of rhesus macaques (Macaca mulatta).

Authors:  Jessica A White; Patricia A Todd; Joann L Yee; Alexis Kalman-Bowlus; Kelsey S Rodgers; Xiaowei Yang; Scott W Wong; Peter Barry; Nicholas W Lerche
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

6.  X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.

Authors:  Sam J Wilson; Edward H Tsao; Benjamin L J Webb; Hongtao Ye; Lucy Dalton-Griffin; Christoforos Tsantoulas; Catherine V Gale; Ming-Qing Du; Adrian Whitehouse; Paul Kellam
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

7.  Oral sexual behaviors associated with prevalent oral human papillomavirus infection.

Authors:  Gypsyamber D'Souza; Yuri Agrawal; Jane Halpern; Sacared Bodison; Maura L Gillison
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

8.  Human herpesvirus 8 seroprevalence among Tobago women and the role of sexual lifestyle behavior.

Authors:  Alicia C McDonald; Camille C Ragin; Frank J Jenkins; Joel Weissfeld; John Wilson; Victor W Wheeler; Jaquie B Wilson; Clareann H Bunker; Emanuela Taioli
Journal:  J Med Virol       Date:  2009-02       Impact factor: 2.327

9.  Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo.

Authors:  Seungmin Hwang; Ting-Ting Wu; Leming M Tong; Kyeong Seon Kim; DeeAnn Martinez-Guzman; Arnaud D Colantonio; Christel H Uittenbogaart; Ren Sun
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

10.  Human herpesvirus 8 in healthy blood donors, Argentina.

Authors:  Celeste L Pérez; Mónica I Tous; Norma Zala; Sofía Camino
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.